MarketCap
Facebook
X
TelegramGeschäftsbericht 2024
hinzugefügt 14.03.2026
ICON Public Limited Company Operativer Cashflow 2011-2026 | ICLR
Operativer Cashflow Jährlich ICON Public Limited Company
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.29 B | 1.16 B | 563 M | 829 M | 568 M | 413 M | 269 M | 383 M | 259 M | 279 M | 170 M | 221 M | 113 M | 20.2 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.29 B | 20.2 M | 467 M |
Operativer Cashflow Vierteljährlich ICON Public Limited Company
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 227 M | - | - | - | 112 M | - | - | - | 143 M | - | - | - | 94.6 M | - | - | - | 40.5 M | - | - | - | 159 M | - | - | - | - | - | - | - | 61.1 M | - | - | - | 38.7 M | - | - | - | 69.4 M | - | - | - | 60.6 M | - | - | - | -5.28 M |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 227 M | -5.28 M | 91 M |
Operativer Cashflow anderer Aktien in der Diagnostik & Forschung
| Name | Operativer Cashflow | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Biomerica
BMRA
|
-3.84 M | $ 2.13 | - | $ 4.89 M |  USA |
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | USA |
 |
Check-Cap Ltd.
CHEK
|
-8 M | - | - | $ 9.42 M |  Israel |
 |
Lantheus Holdings
LNTH
|
390 M | $ 75.5 | -0.31 % | $ 5.1 B | USA |
 |
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
-32.2 M | - | -6.19 % | $ 10.5 M | USA |
 |
Co-Diagnostics
CODX
|
-22.1 M | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Medpace Holdings
MEDP
|
713 M | $ 455.28 | -0.36 % | $ 13.1 B | USA |
 |
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | China |
 |
Mettler-Toledo International
MTD
|
956 M | $ 1 229.6 | -0.87 % | $ 25.3 B |  Schweiz |
 |
Charles River Laboratories International
CRL
|
738 M | $ 156.54 | -0.92 % | $ 7.76 B | USA |
 |
IQVIA Holdings
IQV
|
2.65 B | $ 165.42 | -0.95 % | $ 28.4 B | USA |
 |
Myriad Genetics
MYGN
|
1.8 M | $ 4.6 | -1.29 % | $ 426 M | USA |
 |
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Invitae Corporation
NVTA
|
-493 M | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
-16.3 M | $ 1.25 | -14.38 % | $ 6.81 M | USA |
 |
National Research Corporation
NRC
|
26.4 M | $ 17.47 | -0.26 % | $ 391 M | USA |
 |
Interpace Biosciences
IDXG
|
4.65 M | $ 1.71 | 0.73 % | $ 7.5 M | USA |
 |
IDEXX Laboratories
IDXX
|
1.18 B | $ 569.86 | -1.5 % | $ 45.8 B | USA |
 |
Illumina
ILMN
|
837 M | $ 122.99 | -0.65 % | $ 19.6 B | USA |
 |
Guardant Health
GH
|
-185 M | $ 84.35 | -0.65 % | $ 10.6 B | USA |
 |
QIAGEN N.V.
QGEN
|
674 M | - | - | $ 10.6 B |  Niderland |
 |
Pacific Biosciences of California
PACB
|
-111 M | $ 1.38 | -1.08 % | $ 414 M | USA |
 |
Celcuity
CELC
|
-83.5 M | $ 103.02 | -3.49 % | $ 4.06 B | USA |
 |
Precipio
PRPO
|
-3.56 M | $ 26.93 | - | $ 35 M | USA |
 |
Personalis
PSNL
|
-45.2 M | $ 7.71 | 1.37 % | $ 457 M | USA |
 |
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.64 B | $ 263.52 | -0.36 % | $ 21.9 B | USA |
 |
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | Israel |
 |
RadNet
RDNT
|
299 M | $ 60.39 | -2.19 % | $ 4.54 B | USA |
 |
ENDRA Life Sciences
NDRA
|
-7.4 M | $ 3.41 | -2.16 % | $ 1.83 M | USA |
 |
NeoGenomics
NEO
|
5.23 M | $ 7.91 | -2.35 % | $ 1.01 B | USA |
 |
Agilent Technologies
A
|
1.48 B | $ 111.72 | -0.27 % | $ 34 B | USA |
 |
Natera
NTRA
|
-432 M | $ 194.13 | -2.98 % | $ 19.1 B | USA |
 |
CareDx, Inc
CDNA
|
42 M | $ 17.24 | -1.82 % | $ 919 M | USA |
 |
OPKO Health
OPK
|
-183 M | $ 1.14 | -0.88 % | $ 791 M | USA |
 |
Senseonics Holdings
SENS
|
-59.1 M | $ 6.58 | -0.68 % | $ 275 M | USA |
 |
Castle Biosciences
CSTL
|
64.9 M | $ 25.84 | 0.35 % | $ 718 M | USA |
 |
Sotera Health Company
SHC
|
287 M | $ 13.77 | -0.79 % | $ 3.91 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.89 B | $ 194.57 | -0.54 % | $ 21.6 B | USA |
 |
DarioHealth Corp.
DRIO
|
-25.9 M | $ 7.37 | -1.73 % | $ 29.4 M | Israel |